期刊
BIOMOLECULES
卷 11, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/biom11101425
关键词
CD28(null) T-cells; senescence; COVID-19; inflammation; cytotoxicity; immune decline
资金
- NIH [HL148337, AI142200]
The severity of COVID-19 infection is related to various risk factors, including age and underlying conditions, such as the increase of CD28(null) cells which may worsen the disease and predispose patients to the impact of COVID-19. Possible treatment methods need to be considered for patients with high counts of CD28(null) senescent T-cells.
Coronavirus disease 2019 (COVID-19), a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes infectious disease, and manifests in a wide range of symptoms from asymptomatic to severe illness and even death. Severity of infection is related to many risk factors, including aging and an array of underlying conditions, such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD), and cancer. It remains poorly understood how these conditions influence the severity of COVID-19. Expansion of the CD28(null) senescent T-cell populations, a common phenomenon in aging and several chronic inflammatory conditions, is associated with higher morbidity and mortality rates in COVID-19. Here, we summarize the potential mechanisms whereby CD28(null) cells drive adverse outcomes in disease and predispose patients to devastating COVID-19, and discuss possible treatments for individuals with high counts of CD28(null) senescent T-cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据